Concepedia

Jessica D. Lang

JD

13

Publications

636

Citations

12

H-Index

1997

Active since

Affiliations

Translational Genomics Research Institute(Current)

University of North Carolina at Chapel Hill

University of British Columbia

UNC Lineberger Comprehensive Cancer Center

Mayo Clinic in Arizona

Jessica D. Lang is an author at Translational Genomics Research Institute specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

1997–2024

13

Publications

13

The histone methyltransferase <scp>EZH2</scp> is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type

Yemin Wang, Shary Yuting Chen, Anthony N. Karnezis et al. · The Journal of Pathology · 2017 · 103 citations · Full text

The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer

Raffaella Soldi, Tithi Ghosh, Alexis Weston et al. · PLoS ONE · 2020 · 80 citations · Full text

, , +17

Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type

Yemin Wang, Shary Yuting Chen, Shane Colborne et al. · Molecular Cancer Therapeutics · 2018 · 74 citations · Full text

Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition

Jessica D. Lang, William P.D. Hendricks, Krystal A. Orlando et al. · Clinical Cancer Research · 2018 · 68 citations · Full text

Prostaglandin E2 Induces miR675-5p to Promote Colorectal Tumor Metastasis via Modulation of p53 Expression

Bo Cen, Jessica D. Lang, Yuchen Du et al. · Gastroenterology · 2019 · 63 citations · Full text

, , +10

Rows per page

1–5 of 13